Category: Autopsy
-
LinkedIn’s Positioning Advice Is Creating the Problem It Claims to Solve
Before diving in, I respect both Anthony and Viktar. They’re helping companies clarify their messaging, and that matters. However, a fundamental confusion is occurring that needs to be addressed. This isn’t about calling anyone out. It’s about clarifying what positioning actually means versus what most people think it means. Also, the Emperor’s image source. Let’s…
-
TD’s Investor Day Autopsy: Great Plumbing, Weak Architecture
“I’m excited we’re getting back to winning.” — Raymund Chun With that declaration, TD’s leadership kicked off an Investor Day (September 29, 2025) designed to signal a reset and a return to form. It was a masterclass in financial communications. The team framed a necessary overhaul around three universally agreed-upon promises: simpler, faster, and more…
-
Autopsy: Kyle Poyar’s Fyxer Growth Analysis
Why This Analysis Exists Kyle Poyar is doing great work. His newsletter, Growth Unhinged, consistently delivers sharp insights on go-to-market strategy, pricing, and growth mechanics. His decision to go all-in on the newsletter is admirable. It takes conviction to bet on your own platform and point of view. This analysis isn’t a critique of Kyle.…